Accelerated epigenetic aging as a modifier of homocysteine‐associated cognitive decline: Findings from NHANES
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Haoxuan Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Grade 2023, Clinical Medicine, Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Aging, Cognitive Dysfunction, Epigenesis, Genetic, Homocysteine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
INTRODUCTION Hyperhomocysteinemia represents a modifiable risk factor for cognitive decline and dementia, yet the role of epigenetic aging mechanisms in mediating this association remain poorly characterized, limiting development of targeted interventions. METHODS We analyzed 1343 National Health and Nutrition Examination Survey participants aged ≥ 60 years using weighted regression, cubic splines, and mediation analyses. An independent cohort of 2073 participants validated findings. RESULTS Elevated homocysteine concentrations were significantly associated with reduced cognitive processing speed. GrimAge2 epigenetic age acceleration significantly mediated this association, accounting for 33.3% of the total effect. β2‐microglobulin emerged as the strongest mediating component, explaining 38.8% of the homocysteine–cognition relationship. Folate demonstrated cognitive protection through homocysteine reduction (18.7% of total effect) without modulating downstream pathological cascades. CONCLUSION Epigenetic aging‐associated neuroinflammation serves as a key mechanistic link between hyperhomocysteinemia and cognitive decline. The neuroprotective effects of folate are mediated specifically through homocysteine reduction, providing novel mechanistic insights for precision prevention strategies in cognitive aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grade 2023, Clinical Medicine, Hebei Medical University, Shijiazhuang, China.
- Department of Human Anatomy, Neuroscience Research Center, Hebei Medical University, Shijiazhuang, China.
- Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Shijiazhuang, China.
- Grade 2024, Clinical Medicine, Hebei Medical University, Shijiazhuang, China.
- Grade 2024, Integrated Traditional Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, China.
- Grade 2022, Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, H., Chen, Y., Wang, Z., Wang, Y., Bi, R., Hou, J., Chen, H., Zhang, Z., Guo, Z., Chen, Z., Cui, H., & Li, S. (2026). Accelerated epigenetic aging as a modifier of homocysteine‐associated cognitive decline: Findings from NHANES. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71349
Vancouver
Li H, Chen Y, Wang Z, Wang Y, Bi R, Hou J, et al. Accelerated epigenetic aging as a modifier of homocysteine‐associated cognitive decline: Findings from NHANES. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71349
BibTeX
@article{Li2026,
author = {Li, Haoxuan and Chen, Yuhan and Wang, Zhe and Wang, Yankun and Bi, Ran and Hou, Jiayu and Chen, Huan and Zhang, Zixuan and Guo, Zhenhao and Chen, Zhuo and Cui, Huixian and Li, Sha},
title = {Accelerated epigenetic aging as a modifier of homocysteine‐associated cognitive decline: Findings from NHANES},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71349}
}
EUVIMED